| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9327396 | Gynecologic Oncology | 2005 | 4 Pages |
Abstract
IFRT is effective in controlling localized recurrences of ovarian cancer, especially after they are optimally debulked (89% local control and 50% 5-year overall survival in this subgroup), and is relatively well tolerated in these heavily pretreated patients.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
K.V. Albuquerque, R. Singla, R.K. Potkul, D.M. Smith, S. Creech, S. Lo, B. Emami,